Photochemically Stable Silver Complexes for Sustained Antimicrobial Action

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Silver-based antimicrobial agents face issues with photochemical instability and low water solubility, leading to rapid neutralization of silver ions, which limits their effectiveness and requires frequent application, and there is a need for more stable alternatives to address bacterial resistance.

Innovation Solution

Development of photochemically stable monovalent anionic and cationic silver complexes coordinated with thiolic sulfur atoms, specifically in the form of Ag+---[L1 - M+] and Ag+---[L2 H+ ] Y-, which are prepared in an aqueous medium and can be used in combination with other antimicrobial agents, enhancing stability and microbial activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional silver salts (silver nitrate, silver sulfadiazine) are used as antimicrobial agents, then antimicrobial activity is achieved through silver ion release, but photochemical instability occurs leading to rapid neutralization of silver ions and requiring frequent application

Engineering Contradiction:
Improvephotochemical stabilityVSAvoidduration of antimicrobial activity
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent introduces organic ligands (thiols, amines, carboxylic acids) as intermediary molecules that coordinate with silver ions to form stable complexes. These ligands act as mediators between the silver ion and the environment, preventing direct interaction with light and other degrading factors while maintaining antimicrobial activity. The coordination chemistry creates a protective shell around the silver ion, ensuring sustained release and prolonged effectiveness.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates composite silver complexes by combining silver ions with organic ligands having specific functional groups. These composite structures integrate the antimicrobial properties of silver with the stabilizing characteristics of the organic molecules, resulting in materials that exhibit both photochemical stability and sustained biological activity. The composite nature allows tuning of properties through ligand selection.

Inventive Principle:
Principle #40Composite materials

2Reliability

If silver salts are applied topically to wounds, then antimicrobial effect is achieved, but large amounts of substance are required and the amount of silver released is not clearly defined creating toxicity concerns

Engineering Contradiction:
Improveantimicrobial effectivenessVSAvoidtoxicity to healthy tissue
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the chemical parameters of silver compounds by changing from simple salts to coordinated complexes with specific ligands. This parameter change affects the solubility, stability, and controlled release characteristics of silver, enabling lower effective doses. The coordination environment controls the rate of silver ion release, preventing sudden high concentrations that could cause toxicity while maintaining sustained therapeutic levels.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The organic ligands serve as intermediaries that control and modulate the release of silver ions to the biological environment. Instead of direct release of free silver ions which can be toxic, the ligands mediate a controlled, sustained release that maintains therapeutic effectiveness while reducing peak concentrations that could harm healthy tissue. The ligands themselves also contribute to the overall antimicrobial activity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If silver sulfadiazine creams are used to enable lower amounts to be effective, then antimicrobial activity is improved, but silver ions are rapidly neutralized requiring daily or more frequent application

Engineering Contradiction:
Improveamount of silver requiredVSAvoidduration of silver ion activity
Core Design Contradiction:
Quantity of substanceVSDuration of action of stationary object

Solution Approach 1:

The patent designs silver complexes that provide continuous, sustained release of silver ions over extended periods. The coordination complexes maintain a steady supply of active silver ions rather than rapid initial release followed by quick depletion. This continuous action eliminates the need for frequent reapplication, as the complexes maintain therapeutic levels throughout the day and beyond, providing uninterrupted antimicrobial protection.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The silver complexes are designed to be self-sustaining in their antimicrobial action. The ligand structure and silver coordination create a system that automatically maintains therapeutic concentrations through controlled equilibrium release, without requiring external replenishment or frequent application. The complexes essentially service themselves by maintaining their own effective concentration through the dynamic equilibrium of the coordination chemistry.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The complexes demonstrate prolonged photochemical and thermal stability, allowing for safe storage and prolonged antimicrobial activity, even when exposed to light, and show enhanced microbial activity when combined with other agents, overcoming the limitations of traditional silver salts.

Implementation Method 1

the Ag+ ion is coordinated to the thiolic sulfur atom of [L1 - M+] and [L2 H+] respectively

Methodology Applied
Scientific EffectCoordination chemistry:

Implementation Method 2

they act by discharging silver ions when in contact with wound exudate

Methodology Applied
Scientific EffectIon release:

Data Source

PatentEP3004064B1Pharmaceutical compositions based on photochemically stable silver complexes, chlorexidine and cationic surfactants
Publication Date: 2017.11.01 PAVIA FARM
  • EP3004064B1 patent drawing
  • EP3004064B1 patent drawing
  • EP3004064B1 patent drawing

AI summary

The present invention generally relates to silver complexes of formula (I) and (II), having high stability and showing antimicrobial activity. The invention also relies on compositions containing said photochemically stable silver complexes of formula (I) and (II), optionally admixed with at least another antimicrobial agent, thus enhancing their antimicrobic activity.